RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.

Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.

Add to Collection
2021 May Clinical Guidelines and Recommendations Fist_Author_Year_PM

Full Author : ['Agrawal, Rupesh', 'Testi, Ilaria', 'Lee, Cecilia S', 'Tsui, Edmund', 'Blazes, Marian', 'Thorne, Jennifer E', 'Okada, Annabelle A', 'Smith, Justine R', 'McCluskey, Peter J', 'Kempen, John H', 'Tappeiner, Christoph', 'Agarwal, Manisha', 'Bodaghi, Bahram', 'Nguyen, Quan Dong', 'Gupta, Vishali', 'De Smet, Marc D', 'Zierhut, Manfred', 'Pavesio, Carlos']
Journal Title : The British journal of ophthalmology
Chapter : Section8
Journal Year : 2021

BACKGROUND: Immunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections.....

Keywords : ['noninfectious uveitis', 'immunomodulatory therapy', 'evolve consensus', 'pandemic']